March-April 2013 - Volume 19 - Issue 4
pp: 677-888,E51-E64

The CCFA Research Agenda

Challenges in IBD Research: Update on Progress and Prioritization of the CCFA's Research Agenda

Denson, Lee A.; Long, Millie D.; McGovern, Dermot P. B.; More

Inflammatory Bowel Diseases. 19(4):677-682, March-April 2013.

Anti–Tumor Necrosis Factor α Prevents Bowel Fibrosis Assessed by Messenger RNA, Histology, and Magnetization Transfer MRI in Rats With Crohn's Disease

Adler, Jeremy; Rahal, Kinan; Swanson, Scott D.; More

Inflammatory Bowel Diseases. 19(4):683-690, March-April 2013.

Aneuploidy-Associated Gene Expression Signatures Characterize Malignant Transformation in Ulcerative Colitis

Gerling, Marco; Nousiainen, Kari; Hautaniemi, Sampsa; More

Inflammatory Bowel Diseases. 19(4):691-703, March-April 2013.

Reduction of CD68+ Macrophages and Decreased IL-17 Expression in Intestinal Mucosa of Patients with Inflammatory Bowel Disease Strongly Correlate With Endoscopic Response and...

Caprioli, Flavio; Bosè, Francesca; Rossi, Riccardo L.; More

Inflammatory Bowel Diseases. 19(4):729-739, March-April 2013.

BTB and CNC Homolog 1 (Bach1) Deficiency Ameliorates TNBS Colitis in Mice: Role of M2 Macrophages and Heme Oxygenase-1

Harusato, Akihito; Naito, Yuji; Takagi, Tomohisa; More

Inflammatory Bowel Diseases. 19(4):740-753, March-April 2013.

Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study

Mayer, Lloyd; Pandak, William M.; Melmed, Gil Y.; More

Inflammatory Bowel Diseases. 19(4):754-760, March-April 2013.

Use and Predictors of Oral Complementary and Alternative Medicine by Patients With Inflammatory Bowel Disease: A Population-Based, Case–Control Study

Koning, Marije; Ailabouni, Ramez; Gearry, Richard B.; More

Inflammatory Bowel Diseases. 19(4):767-778, March-April 2013.

Predictors of Endoscopic Inflammation in Patients With Ulcerative Colitis in Clinical Remission

Rosenberg, Laura; Lawlor, Garrett O.; Zenlea, Talia; More

Inflammatory Bowel Diseases. 19(4):779-784, March-April 2013.

Is Treatment with 6-Mercaptopurine for Colitis Associated with the Development of Colorectal Cancer?

Satchi, Mylan; Korelitz, Burton I.; Panagopoulos, Georgia; More

Inflammatory Bowel Diseases. 19(4):785-788, March-April 2013.

Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-analysis of Population-based Cohort Studies

Lutgens, Maurice W. M. D.; van Oijen, Martijn G. H.; van der Heijden, Geert J. M. G.; More

Inflammatory Bowel Diseases. 19(4):789-799, March-April 2013.

Five-Year Mortality in Colorectal Cancer Patients with Ulcerative Colitis or Crohn's Disease: A Nationwide Population-based Cohort Study

Ording, Anne G.; Horváth-Puhó, Erzsébet; Erichsen, Rune; More

Inflammatory Bowel Diseases. 19(4):800-805, March-April 2013.

Rates and Predictors of Oral Medication Adherence in Pediatric Patients with IBD

LeLeiko, Neal S.; Lobato, Debra; Hagin, Sarah; More

Inflammatory Bowel Diseases. 19(4):832-839, March-April 2013.

A Shift From Oral to Intravenous Iron Supplementation Therapy Is Observed Over Time in a Large Swiss Cohort of Patients With Inflammatory Bowel Disease

Vavricka, Stephan R.; Schoepfer, Alain M.; Safroneeva, Ekaterina; More

Inflammatory Bowel Diseases. 19(4):840-846, March-April 2013.

Predictors of Temporary and Permanent Work Disability in Patients With Inflammatory Bowel Disease: Results of the Swiss Inflammatory Bowel Disease Cohort Study

Siebert, Uwe; Wurm, Johannes; Gothe, Raffaella Matteucci; More

Inflammatory Bowel Diseases. 19(4):847-855, March-April 2013.

Pediatric Ulcerative Colitis Associated with Primary Sclerosing Cholangitis: A Distinct Form of Inflammatory Bowel Disease? The Clinical Relevance of Anti-lactoferrin Antibodies

Bracci, F.; Girolami, E.; Torre, G.; More

Inflammatory Bowel Diseases. 19(4):E56-E57, March-April 2013.

1 2 3 4 5